Your browser doesn't support javascript.
loading
Temporal Patterns of Influenza A and B in Tropical and Temperate Countries: What Are the Lessons for Influenza Vaccination?
Caini, Saverio; Andrade, Winston; Badur, Selim; Balmaseda, Angel; Barakat, Amal; Bella, Antonino; Bimohuen, Abderrahman; Brammer, Lynnette; Bresee, Joseph; Bruno, Alfredo; Castillo, Leticia; Ciblak, Meral A; Clara, Alexey W; Cohen, Cheryl; Cutter, Jeffery; Daouda, Coulibaly; de Lozano, Celina; De Mora, Domenica; Dorji, Kunzang; Emukule, Gideon O; Fasce, Rodrigo A; Feng, Luzhao; Ferreira de Almeida, Walquiria Aparecida; Guiomar, Raquel; Heraud, Jean-Michel; Holubka, Olha; Huang, Q Sue; Kadjo, Herve A; Kiyanbekova, Lyazzat; Kosasih, Herman; Kusznierz, Gabriela; Lara, Jenny; Li, Ming; Lopez, Liza; Mai Hoang, Phuong Vu; Pessanha Henriques, Cláudio Maierovitch; Matute, Maria Luisa; Mironenko, Alla; Moreno, Brechla; Mott, Joshua A; Njouom, Richard; Ospanova, Akerke; Owen, Rhonda; Pebody, Richard; Pennington, Kate; Puzelli, Simona; Quynh Le, Mai Thi; Razanajatovo, Norosoa Harline; Rodrigues, Ana; Rudi, Juan Manuel.
Afiliación
  • Caini S; Netherlands Institute for Health Services Research (NIVEL), Utrecht, The Netherlands.
  • Andrade W; Sección de Virus Respiratorios y Exantemáticos, Instituto de Salud Pública de Chile, Santiago de Chile, Chile.
  • Badur S; Istanbul University, Istanbul, Turkey.
  • Balmaseda A; National Influenza Center, Ministry of Health, Managua, Nicaragua.
  • Barakat A; National Influenza Center, Institut National d'Hygiène, Ministry of Health, Rabat, Morocco.
  • Bella A; National Center for Epidemiology, Surveillance and Health Promotion National Institute of Health, Rome, Italy.
  • Bimohuen A; National Influenza Center, Institut National d'Hygiène, Ministry of Health, Rabat, Morocco.
  • Brammer L; Epidemiology and Prevention Branch, Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, United States of America.
  • Bresee J; Epidemiology and Prevention Branch, Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, United States of America.
  • Bruno A; Centro de Referencia Nacional de Influenza y Otros Virus Respiratorios, Instituto Nacional de Investigación en Salud Pública (INSPI), Guayaquil, Ecuador.
  • Castillo L; National Influenza Center, Ministry of Health, Guatemala City, Guatemala.
  • Ciblak MA; Istanbul University, Istanbul, Turkey.
  • Clara AW; US Centers for Disease Control, Central American Region, Guatemala City, Guatemala.
  • Cohen C; Centre for Respiratory Diseases and Meningitis (CRDM), National Institute for Communicable Diseases, Johannesburg, South Africa.
  • Cutter J; School of Public Health, Faculty of Health Science, University of the Witwatersrand, Johannesburg, South Africa.
  • Daouda C; Communicable Diseases Division, Ministry of Health, Singapore, Singapore.
  • de Lozano C; Respiratory Viruses Unit, Pasteur Institute of Côte d'Ivoire, Abidjan, Côte d'Ivoire.
  • De Mora D; National Influenza Center, Ministry of Health, San Salvador, El Salvador.
  • Dorji K; Centro de Referencia Nacional de Influenza y Otros Virus Respiratorios, Instituto Nacional de Investigación en Salud Pública (INSPI), Guayaquil, Ecuador.
  • Emukule GO; Public Health Laboratory, Department of Public Health, Ministry of Health, Thimphu, Bhutan.
  • Fasce RA; US Centers for Disease Control and Prevention, Nairobi, Kenya.
  • Feng L; Sección de Virus Respiratorios y Exantemáticos, Instituto de Salud Pública de Chile, Santiago de Chile, Chile.
  • Ferreira de Almeida WA; Division of Infectious Disease, Key Laboratory of Surveillance and Early-warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Guiomar R; Ministry of Health, Brasília, DF, Brazil.
  • Heraud JM; National Influenza Reference Laboratory, Infectious Diseases Department, National Institute of Health, Lisbon, Portugal.
  • Holubka O; National Influenza Center, Virology Unit, Institut Pasteur of Madagascar, Antananarivo, Madagascar.
  • Huang QS; L.V.Gromashevsky Institute of Epidemiology and Infectious Diseases National Academy of Medical Science of Ukraine, Kiev, Ukraine.
  • Kadjo HA; Institute of Environmental Science and Research, Wellington, New Zealand.
  • Kiyanbekova L; Respiratory Viruses Unit, Pasteur Institute of Côte d'Ivoire, Abidjan, Côte d'Ivoire.
  • Kosasih H; Zonal Virology Laboratory, Astana Center of Sanitary Epidemiology Expertise, Astana, Kazakhstan.
  • Kusznierz G; US Naval Medical Research Unit No. 2, Jakarta, Indonesia.
  • Lara J; Instituto Nacional de Enfermedades Respiratorias "Dr. Emilio Coni," Santa Fe, Argentina.
  • Li M; National Influenza Center, Ministry of Health, San José, Costa Rica.
  • Lopez L; Division of Infectious Disease, Key Laboratory of Surveillance and Early-warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Mai Hoang PV; Institute of Environmental Science and Research, Wellington, New Zealand.
  • Pessanha Henriques CM; National Institute of Hygiene and Epidemiology, Hanoi, Vietnam.
  • Matute ML; Ministry of Health, Brasília, DF, Brazil.
  • Mironenko A; National Influenza Center, Ministry of Health, Tegucigalpa, Honduras.
  • Moreno B; L.V.Gromashevsky Institute of Epidemiology and Infectious Diseases National Academy of Medical Science of Ukraine, Kiev, Ukraine.
  • Mott JA; National Influenza Center, IC Gorgas, Panama City, Panama.
  • Njouom R; US Centers for Disease Control and Prevention, Nairobi, Kenya.
  • Nurhayati; Service de Virologie, Centre Pasteur du Cameroun, Yaounde, Cameroon.
  • Ospanova A; US Naval Medical Research Unit No. 2, Jakarta, Indonesia.
  • Owen R; Zonal Virology Laboratory, Astana Center of Sanitary Epidemiology Expertise, Astana, Kazakhstan.
  • Pebody R; Vaccine Preventable Diseases Surveillance Section, Health Policy Protection Branch, Office of Health Protection, Department of Health, Woden, Australia.
  • Pennington K; Respiratory Diseases Department, Public Health England, Colindale, United Kingdom.
  • Puzelli S; Vaccine Preventable Diseases Surveillance Section, Health Policy Protection Branch, Office of Health Protection, Department of Health, Woden, Australia.
  • Quynh Le MT; National Influenza Center, National Institute of Health, Rome, Italy.
  • Razanajatovo NH; National Institute of Hygiene and Epidemiology, Hanoi, Vietnam.
  • Rodrigues A; National Influenza Center, Virology Unit, Institut Pasteur of Madagascar, Antananarivo, Madagascar.
PLoS One ; 11(3): e0152310, 2016.
Article en En | MEDLINE | ID: mdl-27031105
ABSTRACT

INTRODUCTION:

Determining the optimal time to vaccinate is important for influenza vaccination programmes. Here, we assessed the temporal characteristics of influenza epidemics in the Northern and Southern hemispheres and in the tropics, and discuss their implications for vaccination programmes.

METHODS:

This was a retrospective analysis of surveillance data between 2000 and 2014 from the Global Influenza B Study database. The seasonal peak of influenza was defined as the week with the most reported cases (overall, A, and B) in the season. The duration of seasonal activity was assessed using the maximum proportion of influenza cases during three consecutive months and the minimum number of months with ≥80% of cases in the season. We also assessed whether co-circulation of A and B virus types affected the duration of influenza epidemics.

RESULTS:

212 influenza seasons and 571,907 cases were included from 30 countries. In tropical countries, the seasonal influenza activity lasted longer and the peaks of influenza A and B coincided less frequently than in temperate countries. Temporal characteristics of influenza epidemics were heterogeneous in the tropics, with distinct seasonal epidemics observed only in some countries. Seasons with co-circulation of influenza A and B were longer than influenza A seasons, especially in the tropics.

DISCUSSION:

Our findings show that influenza seasonality is less well defined in the tropics than in temperate regions. This has important implications for vaccination programmes in these countries. High-quality influenza surveillance systems are needed in the tropics to enable decisions about when to vaccinate.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Virus de la Influenza A / Virus de la Influenza B / Vacunación / Gripe Humana Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2016 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Virus de la Influenza A / Virus de la Influenza B / Vacunación / Gripe Humana Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2016 Tipo del documento: Article País de afiliación: Países Bajos